CYLD and hepatocellular carcinoma: Unlike Ni et al.’s findings, which indicated that miR-362-5p promotes HCC growth and metastasis by targeting CYLD, our study pointed the regulatory role of the miR-362-5p/TLE4 axis in promoting HCC.